Genomic and epigenomic BRCA alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas

JOURNAL ARTICLE published 6 July 2022 in Science Translational Medicine

Authors: Francesca Menghi | Kalyan Banda | Pooja Kumar | Robert Straub | Lacey Dobrolecki | Isabel V. Rodriguez | Susan E. Yost | Harshpreet Chandok | Marc R. Radke | George Somlo | Yuan Yuan | Michael T. Lewis | Elizabeth M. Swisher | Edison T. Liu